[HTML][HTML] A single drop in the eye–effects on the whole body?
A Vaajanen, H Vapaatalo - The open ophthalmology journal, 2017 - ncbi.nlm.nih.gov
A Single Drop in the Eye – Effects on the Whole Body? - PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
A systematic review and meta‐analysis of the association between systemic fluoroquinolones and retinal detachment
C Alves, A Penedones, D Mendes… - Acta …, 2016 - Wiley Online Library
Purpose Several pharmacoepidemiologic studies have been carried out evaluating the risk
of retinal detachment associated with systemic fluoroquinolones. This meta‐analysis aims to …
of retinal detachment associated with systemic fluoroquinolones. This meta‐analysis aims to …
[HTML][HTML] Recommendations to conduct and report systematic reviews in medical literature: a scoping review
A Penedones, C Alves, F Batel-Marques - BMC Medical Research …, 2019 - Springer
Background This scoping review aims to identify, review and characterize the published
recommendations to conduct and/or to report a systematic review in medical interventions …
recommendations to conduct and/or to report a systematic review in medical interventions …
Risk of ophthalmic adverse effects in patients treated with MEK inhibitors: A systematic review and meta-analysis
C Alves, I Ribeiro, A Penedones, D Mendes… - Ophthalmic …, 2016 - karger.com
Objectives: This meta-analysis aims to evaluate the risk of ophthalmic adverse effects
associated with MEK inhibitors. Methods: A literature search was conducted in PubMed and …
associated with MEK inhibitors. Methods: A literature search was conducted in PubMed and …
Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation
VL Serebruany, SD Fortmann, SV Rao… - Thrombosis and …, 2016 - thieme-connect.com
Vorapaxar, a novel antiplatelet thrombin PAR-1 inhibitor, has been evaluated in the
successful TRA2P trial and the failed TRACER trial. The drug is currently approved for post …
successful TRA2P trial and the failed TRACER trial. The drug is currently approved for post …
Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta‐analysis
A Penedones, C Alves… - Acta Ophthalmologica, 2020 - Wiley Online Library
The development of nonarteritic anterior ischaemic optic neuropathy has been described to
phosphodiesterase type 5 inhibitors. The aim of this systematic review and meta‐analysis …
phosphodiesterase type 5 inhibitors. The aim of this systematic review and meta‐analysis …
Outcomes from the first 6 years of operation of the Central Portugal Pharmacovigilance Unit
F Batel-Marques, A Penedones, D Mendes… - Journal of patient …, 2020 - journals.lww.com
Objectives The aim of this study was to analyze and characterize the outcomes of the
Central Portugal Regional Pharmacovigilance Unit over a 6-year period. Methods …
Central Portugal Regional Pharmacovigilance Unit over a 6-year period. Methods …
Ocular immunopathology
MF Ramos, L Teixeira, CR Brandt… - … in Toxicology and Drug …, 2017 - Springer
The eye has traditionally been regarded as an immune privileged site because inflammatory
responses that would otherwise be detrimental to vision are modulated in the ocular …
responses that would otherwise be detrimental to vision are modulated in the ocular …
15th Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systems
I Cavero, H Holzgrefe - Journal of Pharmacological and Toxicological …, 2017 - Elsevier
Introduction This report summarizes and comments key talks on the five traditional senses
(ear, vestibular system, vision, taste, olfaction, and touch) which were delivered during the …
(ear, vestibular system, vision, taste, olfaction, and touch) which were delivered during the …